Research Unit on Pediatric Psychopharmacology

Clinical Studies for Children and Adolescents with Autism Spectrum Disorder,
Pervasive Developmental Disorder (PDD), and Other Disorders

Our list of studies provides contact information and links to basic participation requirements.
Please check this page frequently. New studies will be posted prior to subject recruitment.


Current Autism and PDD Studies

Treatment of Overweight Induced by Antipsychotic Medication in Young People with Autism

Click here for a printable flyer [PDF]

Memantine in Pediatric Patients with Autism

Click here for a printable flyer [PDF]

Preschool Parent Management Training Study

Click here for a printable flyer [PDF]

Study of Investigational Medication and Parent Training Sessions for Treatment of Overactivity, Inattention, and Impulsivity in Children Diagnosed with Autistic Disorder


Click here for a printable flyer [PDF]

CHARTS Website


Completed Autism and PDD Studies

Cholesterol in ASD: Characterization and Treatment

Treatment of Irritability and Aggression Associated with Autistic Disorder

Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotics

CM-AT Enzyme vs. Placebo in the Treatment of Autism

Study of an Investigational Medication for Repetitive Behaviors in Children with Autistic Disorder

Research in Serious Behavioral Problems Associated With Autistic Disorder

Study of a Medication for Gastrointestinal Problems in Autistic Children

Study of the Pharmacokinetic Parameters of Risperidone in Patients with Autism Spectrum Disorders and Tourette Syndrome Ages 4 - 21

Risperidone on Cognitive Motor Performance and Motor Movements in Children with Disruptive Behavior Disorders

Pharmacogenetics of Risperidone in Children with PDD, Ages 4 -21 (Adults eligible)

A Study of Atomoxetine (Strattera™) for Children and Adolescents with Autism, Asperger's Syndrome, or other Pervasive Developmental Disorder (PDD) and Signs of Attention-Deficit/Hyperactivity Disorder (ADHD)


Ritalin® Treatment or Guanfacine for Hyperactivity/Impulsiveness in Children with Pervasive Developmental Disorders

Measurement of Risperidone and 9-hydroxyrisperidone in Saliva and Plasma